SofPulse Expansion The company has launched SofPulse devices and partnered with a government reseller, indicating an active go-to-market strategy and potential opportunities to expand sales through public sector and SDVOSB channels.

Medical Division Growth Leadership hiring for the Medical Division, including a President and Chief Commercial Officer, signals a strategic push into commercialization with potential for enterprise contracts and larger account engagements.

Orthopedic Partnerships Collaborations and evaluations with academic and clinical institutions (Stanford) for post-operative pain and rehab applications point to opportunities to position SofPulse as a standard adjunct in surgery recovery programs.

Global Market Ambition The aggressive international market expansion plan for SofPulse suggests alignment with distributors and healthcare providers overseas, offering partnerships across hospitals, clinics, and rehabilitation centers.

Bioelectronic Platform Endonovo’s Immunotronics and Cytotronics platforms open doors to cross-sell into regenerative medicine programs, tissue engineering labs, and research institutions seeking non-invasive inflammation control and cell therapy tooling.